Strategic partnerships Charter Research is actively partnering with major pharma players, including Eli Lilly, to support clinical trials. This indicates a strong channel for cooperative opportunities, co-development services, and scalable trial support offerings.

Clinical trial focus With involvement in prevention trials such as TRAILBLAZER 3 at multiple sites, Charter Research demonstrates capability in multi-site study execution, patient recruitment support, data handling, and regulatory compliance—areas ripe for services like patient recruitment optimization, site management, and analytics.

Mid-market scale The company operates with 51-200 employees and approximately $10M–$25M in revenue, suggesting mid-market agility and capacity to engage mid- to large-sized sponsors without the complexity of tier-one bidders. This positions them for growth-oriented service partnerships.

Tech-enabled operations Use of enterprise and creative tools (QuickBooks, ADP, Adobe Creative Suite, Google Fonts API) alongside security-conscious practices (X-Content-Type-Options) signals a modern, compliant back office and marketing capability that can support scalable study management, branding, and sponsor communications.

Geographic and regulatory scope Multiple study sites in Florida (Lady Lake and Winter Park) indicate regional specialization with potential to expand geographically. This presents opportunities for site expansion services, local recruitment programs, and regulatory coordination support for sponsors seeking regional trials.